Hawkinson Russ 4/A
4/A · Silverback Therapeutics, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4/AAmended
Hawkinson Russ
Sr. Vice President of Finance
Transactions
- Purchase
Common Stock
2020-12-08$21.00/sh+200$4,200→ 200 total
Footnotes (2)
- [F1]The shares were purchased in the Issuer's initial public offering.
- [F2]On December 8, 2020, the reporting person filed a Form 4 in which he inadvertently reported a purchase of 238 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person purchased 200 shares of the issuer's common stock.